ETHYL PYRAZOLO[1,5-A]PYRAZINE-3-CARBOXYLATE, 95.0%, 5g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(4-nitrobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

1-(tert-Butoxycarbonyl)-1,2,5,6-tetrahydro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine>98.0%(GC)(T)1g

Di-Ammonium oxalate monohydrate, min. 98%, BP, 1 kg, plastic packaging.

3-[5-[(1-METHYL-4-PIPERIDINYL)METHOXY]-2-PYRIMIDINYL]-BENZENEMETHANOL, 95.0%, 100mg

1-(3,4-dimethylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 5g

MTIC, 25mg

4-(2-Chloro-6-((4-methylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine, 95.0%, 250mg

2-Biphenyl-[1,3]dioxol-5-yl-carboxylic acid, 97.0%, 250mg

1-Benzyl-4-methylpiperidin-3-one hydrochloride, 95.0%, 5g

(S)-1-(4-Bromobenzyl)pyrrolidin-3-aminedihydrochloride, 95.0%, 1g

4,6,8-Trimethylquinoline>98.0%(GC)(T)1g

3-Amino-2-fluorobenzoic acid, 97.0%, 250mg